All In Biotech

Drug Trial Radar · NCT06928051

A Study of S-892216 in Participants With COVID-19

Phase 2 Study of S-892216 in Participants Infected With SARS-CoV-2

Last checked: Nov 20, 2026Latest source record: Sep 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 282 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

282

Actual

Start

Jun 6, 2025

Primary completion

Sep 22, 2025

Study completion Sep 22, 2025

Sponsor

Lead sponsor
ShionogiIndustry
Sponsor type
Industry
First posted
Apr 15, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 64 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to investigate the antiviral effect of S-892216 in participants with coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

Conditions

  • COVID-19

Interventions

  • S-892216Drug

    S-892216 will be administered orally as a tablet.

  • PlaceboDrug

    Placebo will be administered orally as a tablet.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in SARS-CoV-2 Viral RNA Level on Day 4 as Assessed by Quantitative Reverse-transcription Polymerase Chain Reaction (qRT-PCR) of Nasopharyngeal (NP) SwabsTime frame: Baseline through Day 4

Locations

57 sites in 2 countries. Site status is shown where the registry gives one.

  • Healthstar Research

    Hot Springs, Arkansas

  • Invictus Clinical Research Group LLC

    Coconut Creek, Florida

  • Hope Clinical Trials

    Coral Gables, Florida

  • Advanced Research for Health Improvement LLC

    Immokalee, Florida

  • LCC Medical Research

    Miami, Florida

  • CCM Clinical Research Group

    Miami, Florida

  • Global Health Clinical Trials

    Miami, Florida

  • Continental Clinical Research

    Miami, Florida

  • Entrust Clinical Research

    Miami, Florida

  • Kendall South Medical Center Inc

    Miami, Florida

  • Palm Springs Community Health Center

    Miami Lakes, Florida

  • Quality Research of South Florida

    Miami Lakes, Florida

  • Oceane7 Medical & Research Center, Inc.

    Miami Lakes, Florida

  • Combined Research Orlando Phase I-IV LLC

    Orlando, Florida

  • Global Clinical Professionals

    St. Petersburg, Florida

  • Balanced Life Health Care Solutions

    Lawrenceville, Georgia

  • PanAmerican Clincal Research

    Brownsville, Texas

  • Alina Clinical Trials LLC

    Dallas, Texas

  • Care United Research, LLC

    Forney, Texas

  • Clinical Research Partners LLC

    Richmond, Virginia

  • Frontier Clinical Research LLC

    Kingwood, West Virginia

  • Japanese Site 10

    Multiple Locations, Japan

  • Japanese Site 11

    Multiple Locations, Japan

  • Japanese Site 12

    Multiple Locations, Japan

  • Japanese Site 13

    Multiple Locations, Japan

  • Japanese Site 14

    Multiple Locations, Japan

  • Japanese Site 15

    Multiple Locations, Japan

  • Japanese Site 16

    Multiple Locations, Japan

  • Japanese Site 17

    Multiple Locations, Japan

  • Japanese Site 18

    Multiple Locations, Japan

  • Japanese Site 19

    Multiple Locations, Japan

  • Japanese Site 1

    Multiple Locations, Japan

  • Japanese Site 20

    Multiple Locations, Japan

  • Japanese Site 21

    Multiple Locations, Japan

  • Japanese Site 22

    Multiple Locations, Japan

  • Japanese Site 23

    Multiple Locations, Japan

  • Japanese Site 24

    Multiple Locations, Japan

  • Japanese Site 25

    Multiple Locations, Japan

  • Japanese Site 26

    Multiple Locations, Japan

  • Japanese Site 27

    Multiple Locations, Japan

Showing 40 of 57 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.